IBDEI1DH ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,24320,2)
 ;;=^82022
 ;;^UTILITY(U,$J,358.3,24321,0)
 ;;=154.2^^136^1487^2
 ;;^UTILITY(U,$J,358.3,24321,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,24321,1,1,0)
 ;;=1^154.2
 ;;^UTILITY(U,$J,358.3,24321,1,2,0)
 ;;=2^ANAL CANAL CANCER
 ;;^UTILITY(U,$J,358.3,24321,2)
 ;;=^267091
 ;;^UTILITY(U,$J,358.3,24322,0)
 ;;=154.3^^136^1487^3
 ;;^UTILITY(U,$J,358.3,24322,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,24322,1,1,0)
 ;;=1^154.3
 ;;^UTILITY(U,$J,358.3,24322,1,2,0)
 ;;=2^ANUS CANCER
 ;;^UTILITY(U,$J,358.3,24322,2)
 ;;=^267092
 ;;^UTILITY(U,$J,358.3,24323,0)
 ;;=164.0^^136^1487^62
 ;;^UTILITY(U,$J,358.3,24323,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,24323,1,1,0)
 ;;=1^164.0
 ;;^UTILITY(U,$J,358.3,24323,1,2,0)
 ;;=2^THYMUS CANCER
 ;;^UTILITY(U,$J,358.3,24323,2)
 ;;=^267145
 ;;^UTILITY(U,$J,358.3,24324,0)
 ;;=164.1^^136^1487^19
 ;;^UTILITY(U,$J,358.3,24324,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,24324,1,1,0)
 ;;=1^164.1
 ;;^UTILITY(U,$J,358.3,24324,1,2,0)
 ;;=2^HEART CANCER
 ;;^UTILITY(U,$J,358.3,24324,2)
 ;;=^267146
 ;;^UTILITY(U,$J,358.3,24325,0)
 ;;=164.2^^136^1487^42
 ;;^UTILITY(U,$J,358.3,24325,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,24325,1,1,0)
 ;;=1^164.2
 ;;^UTILITY(U,$J,358.3,24325,1,2,0)
 ;;=2^MEDIASTINAL CANCER
 ;;^UTILITY(U,$J,358.3,24325,2)
 ;;=^267147
 ;;^UTILITY(U,$J,358.3,24326,0)
 ;;=173.90^^136^1487^58
 ;;^UTILITY(U,$J,358.3,24326,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,24326,1,1,0)
 ;;=1^173.90
 ;;^UTILITY(U,$J,358.3,24326,1,2,0)
 ;;=2^SKIN,MALIGNANT,UNSPEC,SITE UNSPEC
 ;;^UTILITY(U,$J,358.3,24326,2)
 ;;=^340605
 ;;^UTILITY(U,$J,358.3,24327,0)
 ;;=173.91^^136^1487^5
 ;;^UTILITY(U,$J,358.3,24327,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,24327,1,1,0)
 ;;=1^173.91
 ;;^UTILITY(U,$J,358.3,24327,1,2,0)
 ;;=2^BCC SKIN, SITE UNSP
 ;;^UTILITY(U,$J,358.3,24327,2)
 ;;=^340491
 ;;^UTILITY(U,$J,358.3,24328,0)
 ;;=173.92^^136^1487^56
 ;;^UTILITY(U,$J,358.3,24328,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,24328,1,1,0)
 ;;=1^173.92
 ;;^UTILITY(U,$J,358.3,24328,1,2,0)
 ;;=2^SCC SKIN, SITE UNSP
 ;;^UTILITY(U,$J,358.3,24328,2)
 ;;=^340492
 ;;^UTILITY(U,$J,358.3,24329,0)
 ;;=173.99^^136^1487^57
 ;;^UTILITY(U,$J,358.3,24329,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,24329,1,1,0)
 ;;=1^173.99
 ;;^UTILITY(U,$J,358.3,24329,1,2,0)
 ;;=2^SKIN, MALIGNANT SITE UNSP
 ;;^UTILITY(U,$J,358.3,24329,2)
 ;;=^340493
 ;;^UTILITY(U,$J,358.3,24330,0)
 ;;=174.9^^136^1487^9
 ;;^UTILITY(U,$J,358.3,24330,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,24330,1,1,0)
 ;;=1^174.9
 ;;^UTILITY(U,$J,358.3,24330,1,2,0)
 ;;=2^BREAST CANCER-FEMALE,UNSPEC
 ;;^UTILITY(U,$J,358.3,24330,2)
 ;;=^267202
 ;;^UTILITY(U,$J,358.3,24331,0)
 ;;=189.0^^136^1487^54
 ;;^UTILITY(U,$J,358.3,24331,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,24331,1,1,0)
 ;;=1^189.0
 ;;^UTILITY(U,$J,358.3,24331,1,2,0)
 ;;=2^RENAL CELL CANCER
 ;;^UTILITY(U,$J,358.3,24331,2)
 ;;=^73523
 ;;^UTILITY(U,$J,358.3,24332,0)
 ;;=149.0^^136^1487^49
 ;;^UTILITY(U,$J,358.3,24332,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,24332,1,1,0)
 ;;=1^149.0
 ;;^UTILITY(U,$J,358.3,24332,1,2,0)
 ;;=2^PHARYNGEAL CANCER
 ;;^UTILITY(U,$J,358.3,24332,2)
 ;;=^267051
 ;;^UTILITY(U,$J,358.3,24333,0)
 ;;=173.00^^136^1487^24
 ;;^UTILITY(U,$J,358.3,24333,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,24333,1,1,0)
 ;;=1^173.00
 ;;^UTILITY(U,$J,358.3,24333,1,2,0)
 ;;=2^LIP CANCER,SKIN NOS
 ;;^UTILITY(U,$J,358.3,24333,2)
 ;;=^340596
 ;;^UTILITY(U,$J,358.3,24334,0)
 ;;=199.1^^136^1487^41
 ;;^UTILITY(U,$J,358.3,24334,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,24334,1,1,0)
 ;;=1^199.1
 ;;
 ;;$END ROU IBDEI1DH
